Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 Pipeline Update: May 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
Still minor
What survives that test is narrower and more testable than the broad claim it replaces: that brain-penetrant agonism, delivered early, in patients chosen by their biology rather than their diagnosis, and judged against biomarkers rather than questionnaires, might still work
But Eli Lilly is fast catching up, with projected global earnings of nearly 15bn this year for tirzepatide, which unlike semaglutide acts on two sets of the bodys receptors
US$ 21.34
US$ 23.85
US$ 23.77
US$ 23.10
US$ 27.38
